Evidence map›Paper›PMID 42919419›Full record

ArticleBiology of sex differences2026

Single cell landscape of sex differences in the different courses of multiple sclerosis.

Irene Soler-Sáez, Borja Gómez-Cabañes, Rubén Grillo-Risco, Cristina Galiana-Roselló, Lucas Barea-Moya, Héctor Carceller, María de la Iglesia-Vayá, Sara Gil-Perotin, Vanja Tepavčević, Marta R Hidalgo and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Biology of sex differences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Irene Soler-SáezComputational Biomedicine Laboratory, Principe Felipe Research Center (CIPF), Valencia, 46012, Spain.
Borja Gómez-CabañesComputational Biomedicine Laboratory, Principe Felipe Research Center (CIPF), Valencia, 46012, Spain.
Rubén Grillo-RiscoComputational Biomedicine Laboratory, Principe Felipe Research Center (CIPF), Valencia, 46012, Spain.
Cristina Galiana-RosellóComputational Biomedicine Laboratory, Principe Felipe Research Center (CIPF), Valencia, 46012, Spain.
Lucas Barea-MoyaResearch Group in Immunotherapy and Biomodels for Autoimmunity, Instituto de Investigación Sanitaria La Fe, Valencia, 46026, Spain.
Héctor CarcellerNeurobiology Unit, Program in Neuroscience Institute of Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Burjassot, 46100, Valencia, Spain.
María de la Iglesia-VayáJoint Unit in Biomedical Imaging FISABIO-CIPF, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, 46012, Spain.
Sara Gil-PerotinResearch Group in Immunotherapy and Biomodels for Autoimmunity, Instituto de Investigación Sanitaria La Fe, Valencia, 46026, Spain.
Vanja TepavčevićLaboratory of Comparative and Regenerative Neurobiology, Cavanilles Institute of Biodiversity and Evolutionary Biology, University of Valencia, Paterna, 46980, Spain.
Marta R HidalgoComputational Biomedicine Laboratory, Principe Felipe Research Center (CIPF), Valencia, 46012, Spain. marta.hidalgo@uv.es.
Francisco García-GarcíaComputational Biomedicine Laboratory, Principe Felipe Research Center (CIPF), Valencia, 46012, Spain. fgarcia@cipf.es.ORCID https://orcid.org/0000-0001-8354-5636

Funding

Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana CIAICO/2023/149
6 · The paper itself

Abstract

backgroundOne of the major challenges in addressing multiple sclerosis is to understand its progression trajectory. The pathological process transitions from acute phases predominantly driven by inflammation to progressive clinical profiles where neurodegeneration takes precedence. It is known that sex plays a crucial role in this heterogeneity; females are two to three times more likely to suffer from multiple sclerosis, while males suffer from more rapid neurodegeneration with greater severity.

resultsTo gain insight into the sex-based molecular differences, we processed single cell datasets from the central nervous system and the peripheral blood, covering the different courses of multiple sclerosis. We generated cell-type specific landscapes, including gene signatures from differentially expressed genes, functional profiling, pathway activation, and cell-cell communication networks for females, males, and their sex differential profiles. Among our findings, we revealed that female neurons may exhibit protective mechanisms against neurodegeneration. In the inflammatory-predominant forms, female immune cells present an inflammatory core driven by the AP-1 transcription factor, while male adaptive immune cells exhibit higher mitochondrial impairment. Conversely, larger differences are reported in CD8 + T cells progressive forms, with males exhibiting cytolytic profiles that may promote neurodegeneration. Complete results can be explored in the interactive webtool https://irsoler.shinyapps.io/cbl-atlas-ms/ .

conclusionsWe identified cell-type specific sex differences in brain and immune cells that vary in the spectrum of multiple sclerosis. We consider this molecular description a valuable resource to promote future targeted approaches considering the sex of the individual.

Indexed as

Multiple SclerosisSex CharacteristicsFemaleHumansMaleSingle-Cell AnalysisCentral nervous systemExcitotoxicityInflammationMultiple sclerosisMyelin recoveryNeurodegenerationPeripheral immune systemscRNA-seqSex differences

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.